Armand Keating, MD
The ASH leadership is delighted with CRTI’s success. CRTI has become an ASH flagship program as reflected by the passion displayed by the Executive Committee, the faculty, and the participants. As documented in Dr. Gitlin’s article, the metrics show that CRTI is an exemplary model that should be adopted by many specialty societies and has already been emulated by at least one.
I applaud the outstanding contributions of the CRTI co-directors and faculty who have contributed their time and energy over the past decade and encourage anyone called to participate in the program to treat the invitation like the true honor it is.
There are several key features to its success, including the enviable and distinctive 1:1 ratio of faculty to participants. Another feature, one that I have had the privilege to witness, is the ongoing networking among CRTI graduates. I believe that the benefits of the interactions among the participants will continue to accrue in the years to come.
The success of the program is also a tribute to the individual ASH members who have contributed monetarily to the program. I recently spoke with one such donor who said his support for the program is based on his conviction that it provides young hematologists with an outstanding start in a career in clinical research. I also want to recognize the Wallace H. Coulter Foundation both for their generous support of the program’s start-up and for their continued interest to this day.
As with many aspects of clinical research currently, the future of CRTI will have an international focus. We began welcoming participants from outside North America in 2011 and hope to attract more international applicants to the program through our outreach efforts around the globe. We have already been able to build on the program’s success through our partnership with the European Hematology Association in establishing the Translational Research Training in Hematology program. I am also very pleased to share that ASH will be hosting a research skills workshop for hematology faculty in Latin America in advance of the Highlights of ASH® meeting in Santiago, Chile, in 2013.
Bravo CRTI! We congratulate the CRTI participants and faculty on the program’s 10th anniversary, and we look forward to your continued success over the next decade.
2012 CRTI Participants
Staci D. Arnold, MD, MBA, Columbia University Medical Center, New York, NY
Vinai C. Bhagirath, MD, McMaster University, Hamilton, Ontario, Canada
Danielle M. Brander, MD, Duke University, Durham, NC
Tyler W. Buckner, MD, University of North Carolina, Chapel Hill, NC
Jonathon B. Cohen, MD, The Ohio State University-James Cancer Center, Columbus, OH
Kevin J. Curran, MD, Memorial Sloan-Kettering Cancer Center, New York, NY
Alexey V. Danilov, MD, Dartmouth-Hitchcock Medical Center, Lebanon, NH
Adam J. Esbenshade, MD, Vanderbilt University, Nashville, TN
Michael W. Evans, MD, MPH, Penn State Hershey College of Medicine, Hershey, PA
Saar I. Gill, MD, University of Pennsylvania Health System, Philadelphia, PA
Saulius K. Girnius, MD, Boston University School of Medicine, Boston, MA
Patrick T. McGann, MD, Baylor College of Medicine, Houston, TX
Kerri Nottage, MD, St. Jude Children’s Research Hospital, Memphis, TN
Christine Phillips, MD, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
Rajeev Rajendra, MD, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA
Kristen M. Sanfilippo, MD, Washington University, St. Louis, MO
Edward Allan Sison, MD, The Johns Hopkins University, Baltimore, MD
Kendra L. Sweet, MD, H. Lee Moffitt Cancer Center, Tampa, FL
Rachel M. Thienprayoon, MD, The University of Texas Southwestern, Dallas, TX
Kitsada Wudhikarn, MD, University of Iowa, Iowa City, IA
back to top